177 related articles for article (PubMed ID: 30840585)
1. Combined evaluation of genotype and phenotype of thiopurine S-methyltransferase (TPMT) in the clinical management of patients in chronic therapy with azathioprine.
Rucci F; Cigoli MS; Marini V; Fucile C; Mattioli F; Robbiano L; Cavallari U; Scaglione F; Perno CF; Penco S; Marocchi A
Drug Metab Pers Ther; 2019 Mar; 34(1):. PubMed ID: 30840585
[TBL] [Abstract][Full Text] [Related]
2. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017
[TBL] [Abstract][Full Text] [Related]
3. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
4. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
5. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
6. Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
Di Salvo A; Fabiano C; Mannara V; Dimarco M; Orlando A; Affronti M; Macaluso FS; Cottone M
Dig Liver Dis; 2016 Dec; 48(12):1506-1509. PubMed ID: 27665263
[TBL] [Abstract][Full Text] [Related]
7. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.
Pashazadeh P; Marjani A; Asadi J; Khoshnia M
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis and azathioprine treatment: Adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms.
Lorenzoni PJ; Kay CSK; Zanlorenzi MF; Ducci RD; Werneck LC; Scola RH
J Neurol Sci; 2020 May; 412():116734. PubMed ID: 32070863
[TBL] [Abstract][Full Text] [Related]
10. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
11. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
12. A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs.
Skrzypczak-Zielinska M; Borun P; Bartkowiak-Kaczmarek A; Zakerska-Banaszak O; Walczak M; Dobrowolska A; Kurzawski M; Waszak M; Lipinski D; Plawski A; Slomski R
Mol Diagn Ther; 2016 Oct; 20(5):493-9. PubMed ID: 27307154
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity.
Reuther LO; Vainer B; Sonne J; Larsen NE
Eur J Clin Pharmacol; 2004 Jan; 59(11):797-801. PubMed ID: 14634700
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
[TBL] [Abstract][Full Text] [Related]
15. Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
Casajús A; Zubiaur P; Méndez M; Campodónico D; Gómez A; Navares-Gómez M; Villapalos-García G; Soria-Chacartegui P; Novalbos J; Román M; Mejía-Abril G; Ochoa D; Abad-Santos F
Adv Ther; 2022 Apr; 39(4):1743-1753. PubMed ID: 35192152
[TBL] [Abstract][Full Text] [Related]
16. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Takatsu N; Matsui T; Murakami Y; Ishihara H; Hisabe T; Nagahama T; Maki S; Beppu T; Takaki Y; Hirai F; Yao K
J Gastroenterol Hepatol; 2009 Jul; 24(7):1258-64. PubMed ID: 19682195
[TBL] [Abstract][Full Text] [Related]
17. A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations.
Roberts RL; Barclay ML; Gearry RB; Kennedy MA
Clin Chim Acta; 2004 Mar; 341(1-2):49-53. PubMed ID: 14967158
[TBL] [Abstract][Full Text] [Related]
18. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
Clunie GP; Lennard L
Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
Breen DP; Marinaki AM; Arenas M; Hayes PC
Liver Transpl; 2005 Jul; 11(7):826-833. PubMed ID: 15973722
[TBL] [Abstract][Full Text] [Related]
20. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.
Xin HW; Xiong H; Wu XC; Li Q; Xiong L; Yu AR
Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
